Integrative genomic analysis for the discovery of biomarkers in prostate cancer

Biomarker Insights

Volumn 9, Issue , 2014, Pages 39-51

  Hicks, Chindo ^a,b,c   Koganti, Tejaswi ^a   Giri, Shankar ^a   Tekere, Memory ^d   Ramani, Ritika ^a   Sitthi Amorn, Jitsuda ^a   Vijayakumar, Srinivasan ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LUSAKA   (Zambia)

^d UNIVERSITY OF SOUTH AFRICA   (South Africa)

Author keywords

Gene expression; Genetic variants; GWAS; Prostate cancer

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER; JANUS KINASE 2; PROLACTIN; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84903997392     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s13729     Document Type: Article

References (57)

1. Hindorff LA, Sethupathy P, Junkins HA, etal. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009; 106(23): 9362-7.
2. Hicks C, Miele L, Koganti T, Vijayakumar S. Comprehensive assessment and network analysis of the emerging genetic susceptibility landscape of prostate cancer. Cancer Inform. 2013; 12: 175-91.
3. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet. 2010; 86: 581-91.
4. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009; 461: 218-23.
5. Hicks C, Asfour R, Pannuti A, Miele L. An integrative genomics approach to biomarker discovery in breast cancer. Cancer Inform. 2011; 10: 185-204.
6. Peng G, Luo L, Zhu Y, Dong H, Amos CI, Xiong M. Genome-wide gene pathway analysis. Eur J Hum Genet. 2010; 18: 1045-53.
7. Calvo A, Xiao N, Kang J, etal. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 2002; 62(18): 5325-35.
8. Paulo P, Ribeiro FR, Santos J, etal. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Neoplasia. 2012; 14(7): 600-11.
9. LaTulippe E, Satagopan J, Smith A, etal. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002; 62(15): 4499-506.
10. Chetcuti A, Margan S, Mann S, etal. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate. 2001; 47(2): 132-40.
11. Ioannidis JP, Boffetta P, Little J, etal. Assessment of cumulative evidence on genetic associations: Interim guidelines. Int J Epidemiol. 2008; 37: 120-32.
12. Khoury MJ, Bertram L, Boffetta P, etal. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation in human diseases. Am J Epidemiol. 2009; 170: 269-79.
13. Sagoo GS, Little J, Higgins JP. Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med. 2009; 6: e28.
14. Moher D, Liberati A, Tetzlaff J. Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151: 264-9.
15. Liberati A, Altman DG, Tetzlaff J, etal. The PRISMA statement for reporting systematic reviews and meta-analyses studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7): e1000100.
16. dbSNP. Available at http: //www.ncbi.nlm.nih.gov/SNP/
17. Human Genome Nomenclature Committee (HGNC) Database. Available at http: //www.genenames.org/
18. Jia Z, Wang Y, Sawyers A, etal. Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Res. 2011; 71(7): 2476-87.
19. Benjamini Y, Hochberg Y. Controlling the false discovery rat: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995; 57(1): 289-300.
20. Ramacher MD, Mcshane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol. 2002; 9(3): 505-11.
21. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P. GenePattern 2.0. Nat Genet. 2006; 38(5): 500-1.
22. Morrissey ER, Diaz-Uriarte R. Pomelo II: finding differentially expressed genes. Nucleic Acids Res. 2009; 37: W581-6.
23. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Nat Acad Sci U S A. 1998; 95: 14863-8.
24. Ashburner M, Ball CA, Blake JA, etal. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1): 25-9.
25. Ingenuity Pathways Analysis (IPA). Ingenuity Pathways Analysis (IPA) system. Redwood, CA: Ingenuity Systems, Inc. Available at http: //www.ingenuity.com/
26. Broer L, Lill CM, Schuur M, etal. Distinguishing true from false positives in genomic studies: p values. Eur J Epidemiol. 2013; 28(2): 131-8.
27. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001; 29(3): 306-9.
28. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010; 26(3): 132-41.
29. Knudsen KE, Penning TM. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab. 2010; 21(5): 315-24.
30. Chen S, Kesler CT, Paschal BM, Balk SP. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1. J Biol Chem. 2009; 284: 25576-84.
31. Xu K, Shimelis H, Linn DE, etal. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009; 15: 270-82.
32. Gaughan L, Logan IR, Neal DE, Robson CN. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005; 33: 13-26.
33. Kaarbø M, Klokk TI, Saatcioglu F. Androgen signaling and its interactions with other signaling pathways in prostate cancer. Bioessays. 2007; 29(12): 1227-38.
34. Zambon CF, Prayer-Galetti T, Basso D, etal. Effectiveness of the combined evaluation of KLK3genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis. J Urol. 2012; 188(4): 1124-30.
35. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci. 1998; 35: 275-368.
36. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004; 25(2): 276-308.
37. Scher HI, Sawyers CL. Biology of progressive castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol. 2005; 23(32): 8253-61.
38. Papatsoris AG, Karamouzis MV, Papavassiliou AG. Novel Insights into the implications of the IGF-1 network in prostate cancer. Trends Mol Med. 2005; 11(2): 52-5.
39. Chan JM, Stampfer MJ, Giovannucci E, etal. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998; 279: 563-6.
40. Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem. 2006; 99: 392-401.
41. Gregory CW, He B, Johnson RT, etal. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 2001; 61: 4315-9.
42. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002; 21: 4037-48.
43. De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES, De Siervi A. BRCA1 and P53 regulate critical prostate cancer pathways. Prostate Cancer Prostatic Dis. 2013; 16: 233-8.
44. Linja MJ, Visakorpi T. Alterations of androgen receptor in prostate cancer. J Steroid Biochem Mol Biol. 2004; 92: 255-65.
45. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001; 1: 34-45.
46. Dagvadorj A, Collins S, Jomain JB, etal. Autocrine prolactin promotes prostate cancer cell growth via janus kinase-2-signal transducer and activator transcription-5a/b signaling pathway. Endocrinology. 2007; 148(7): 3089-101.
47. Kwon EM, Holt SK, Fu R, etal. Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiol. 2012; 36: 347-53.
48. Jia P, Liu Y, Zhao Z. Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. BMC Syst Biol. 2012; 6(suppl 3): 513.
49. Chen X, Wang L, Hu B, Guo M, Barnard J, Zhu X. Pathway-based analysis of genome-wide association studies using supervised principal components. Genet Epidemiol. 2010; 34: 716-24.
50. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genome-wide association studies. Am J Hum Genet. 2007; 81: 1278-83.
51. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science. 2002; 297: 1143.
52. Buckland PR. Allele-specific gene expression differences in humans. Hum Mol Genet. 2004; 13(2): R255-60.
53. Palacios R, Gazave E, Goñi J, etal. Allele-specific gene expression is wide-spread across the genome and biological processes. PLoS One. 2009; 4(1): e4150.
54. Meyer KB, Maia AT, O'Reilly M, etal. Allele-specific up-regulation of FGFR2increases susceptibility to breast cancer. PLoS Biol. 2008; 6(5): e108.
55. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic populations. Nat Genet. 2007; 39(2): 226-31.
56. Zhang W, Duan S, Kistner EO, etal. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet. 2008; 82: 631-40.
57. Stranger BE, Nica AC, Forrest MS, etal. Population genomics of human gene expression. Nat Genet. 2007; 39(10): 1217-24.